Beijing Tricision Biotherapeutics Inc
2 clinical trials · Sponsor
◉ Watch Beijing Tricision Biotherapeutics Inc
| Record | Firm | Date |
|---|---|---|
| Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma (NCT07715097) | Beijing Tricision Biotherapeutics Inc | 2026-09-30 |
| Targeted Survivin DC Cell Injection for the Treatment of GBM (NCT06524063) | Beijing Tricision Biotherapeutics Inc | 2024-08-01 |
Track Beijing Tricision Biotherapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.